World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3615)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

909

HTML

1636

Figures (1-7)

243

Tables (1-1)

221

Sum=3009

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

393

Sum=477

Apr 28, 2025 (publication date) through Sep 16, 2025

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Yu JW, Zhao Q, Li PX, Zhang YX, Gao BX, Xiang LB, Liu XY, Wang L, Sun YJ, Yang ZZ, Shi YJ, Chen YF, Yu MB, Zhang HK, Zhang L, Xu QH, Ren L, Li D, Lyu Y, Ren FG, Lu Q. Duodenal mucosal ablation with irreversible electroporation reduces liver lipids in rats with non-alcoholic fatty liver disease. World J Gastroenterol 2025; 31(16): 105188 [PMID: 40308802 DOI: 10.3748/wjg.v31.i16.105188]
URL:	https://www.wjgnet.com/1007-9327/full/v31/i16/105188.htm

Number	Citing Articles
1	Khaled Mohamed Mohamed Koriem. Duodenal mucosal ablation with irreversible electroporation in non-alcoholic fatty liver disease: Roadmap of the future treatment. World Journal of Gastroenterology 2025; 31(32): 109235 doi: 10.3748/wjg.v31.i32.109235 Abstract(388) \| Core Tip(420) \| Full Article(HTML)(1332) \| Full Article with Cover (PDF)-643K(50) \| Audio-112K(9) \| Peer-Review Report-225K(20) \| Answering Reviewers-197K(20) \| Full Article (PDF)-354K(37) \| Full Article (XML)-44K(16) \| Times Cited (0) \| Total Visits (2545) \| Open
2	Amedeo Lonardo, Ming-Hua Zheng. Targeting duodenum to reverse MASLD. Exploration of Digestive Diseases 2025; 4 doi: 10.37349/edd.2025.100577
3	Mariana M Ramírez-Mejía, Nahum Méndez-Sánchez. Duodenal mucosal ablation by irreversible electroporation: Modulating the gut-liver axis in metabolic steatotic liver disease. World Journal of Hepatology 2025; 17(8): 108845 doi: 10.4254/wjh.v17.i8.108845 Abstract(101) \| Core Tip(89) \| Full Article(HTML)(196) \| Full Article with Cover (PDF)-3188K(17) \| Audio-327K(4) \| Peer-Review Report-259K(14) \| Answering Reviewers-79K(14) \| Full Article (PDF)-2895K(25) \| Full Article (XML)-64K(13) \| Times Cited (0) \| Total Visits (879) \| Open
4	Cornelius J Fernandez, Sweekruti Jena, Vijaya Lakshmi, Joseph M Pappachan. Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease. World Journal of Gastroenterology 2025; 31(28): 109468 doi: 10.3748/wjg.v31.i28.109468 Abstract(145) \| Core Tip(135) \| Full Article(HTML)(1484) \| Full Article with Cover (PDF)-2487K(49) \| Audio-1203K(14) \| Peer-Review Report-243K(23) \| Answering Reviewers-61K(26) \| Full Article (PDF)-2219K(75) \| Full Article (XML)-117K(24) \| Times Cited (0) \| Total Visits (2707) \| Open